Summary A monoclonal antibody, FBT3, was raised against Tn positive erythrocytes and, using immunohistochemistry, fresh and fixed tissues from patients with cancer were studied to detect any expression of a Tn-like epitope. Expression was found in neoplastic cells, usually both in cytoplasm and on cell membranes, from 104 of 147 cases of carcinoma and 1 of 13 cases of lymphoma, but rarely in adjacent, morphologically normal cells. Tn (Issitt, 1981) . The molecule consists of a polypeptide chain to which are attached a number of sugar residues and one or more terminal sialic acid molecules. Sialoglycoprotein bears two cryptic antigenic determinants termed T and Tn and all individuals have in their plasma anti-T and anti-Tn antibodies which are thought to develop in response to organisms of their intestinal flora which bear related antigens. Removal of the terminal sialic acid of sialoglycoprotein in erythrocytes leads to uncovering of the T antigen; this is not uncommon and is usually due to bacterial infection and the activity of bacterial neuraminidase. Lack of the penultimate residue, galactose (and the terminal sialic acid) leads to uncovering of the Tn antigen. Biochemically, Tn antigen expression corresponds to exposure of N-acetyl-D-galactosamine residues 0-glycosidically linked to serine or threonine.
Tn expression is thought to be rare and has been reported in a few cases of malignant or premalignant haemopoietic disorders in which its presence has been detected following observation of polyagglutination of the erythrocytes by all blood grouping antisera. In these conditions the appearance of Tn appears to be due to a deficiency of the enzyme, 3-,B-D-galactosyl transferase which appears to result from a somatic mutation at the gene locus for this enzyme (Cartron et al., 1978) .
As part of a study into the importance of somatic mutation in human cells, we (Springer et al., 1979; Springer, 1984; Springer et al., 1985a) . In extensive studies using polyclonal antibodies they have shown that the T antigen is often expressed in cases of cancer, particularly breast cancer; in more limited studies, principally using antibody absorption, they have found that the Tn antigen may also be expressed in some instances. Recently Hirohashi et al. (1985) (Bird & Wingham, 1973) . Male BALB/c mice were injected intraperitoneally at intervals of three weeks with 0.2ml of a 5% suspension of Tn positive erythrocytes and a booster dose of antigen was given 4 days prior to hybridoma formation which was carried out using previously described techniques (Hurrell, 1982) . The spleen cells from the immunized mice were fused with the mouse myeloma cell line P3.X63.Ag8 and supernatants of hybrids which had grown were screened against Tn positive and negative erythrocytes using haemagglutination and indirect fluorescence. Positive antibody producing hybrids were subcloned twice by limiting dilution and the resultant clones screened for production of anti-Tn antibodies by demonstrating reactivity against 7 examples of Tn positive erythrocytes and lack of reactivity against Tn negative erythrocytes which showed ABO, Rh, Ii, Fy, K, MNS, P, Lu, Jk, Le, Xg, Wr, En(a-), Mg+, SD+, Sd(a++), St(a+) , and T blood group specificities. From 6 anti-Tn clones one, FBT3, was selected to be further characterized and to be used in immunohistochemical studies because of its very avid reactivity with Tn positive erythrocytes. Isotyping of FBT3 by an immunodot blot technique (McDougal et al., 1983) using monospecific antisera showed it to be of the IgM class. SDS-polyacrylamide-gel electrophoresis of erythrocyte membranes and immunoblotting was carried out using previously established techniques (Merry et al., 1986 ). Haemagglutination inhibition studies were performed on culture supernatant as previously described (Springer et al., 1985b The working solution of FBT3 was a 1:100 dilution of the hybridoma culture supernatant in TRIS-saline buffer, pH 7.6, and had a protein concentration of 0.05 pg ml-1. All tissues were stained using a modification of the indirect AvidinBiotin-Complex (ABC) technique of Hsu et al. (1981) as or similar to the Tn epitope can be expressed by malignant cells. The antigen was detected both on the surface and within the cytoplasm and, by contrast with many other tumour associated antigens, positive staining was usually quite intense and background staining insignificant. This adds to the usefulness of the antigen as a tumour marker.
The expression of T and Tn in tumours has previously been studied by Springer et al. (1979; 1985a, b) . Most of their studies have involved expression of the T antigen, which has been found to be frequently expressed by cancer cells. More recently, they have shown that Tn may also be expressed by cancer cells. In the studies of Tn they principally used absorption of polyclonal human anti-Tn by tissue, decrease in antibody titre as their assay, and studied breast cancer as the prototypic cancer. They carried out limited studies using immunohistochemistry to detect binding of polyclonal human anti-Tn and reported that normal cells either did not stain or stained weakly whereas tumour cells stained much more intensely. They raised monoclonal antibodies to Tn using breast cancer tissue as the immunogen and, using histochemistry, they noted that 3 of 5 breast cancers showed positive staining, and that normal structures D.J. ROXBY et al. a2 a showed less, although often some, staining (Springer et al., 1985a) . Hirohashi et al. (1985) characterized as Tn two monoclonal antibodies raised against cancer cells and indicated that they labelled neoplastic tissues from cancer patients but not the corresponding normal tissues from normal individuals.
The present study used a monoclonal antibody raised against Tn positive erythrocytes and the results using this antibody showed that 104 of 147 cases of cancer were positive. We have no proof that in cancer cells the antibody was detecting the Tn epitope; it may have been detecting a closely related structure but the term Tn is used for convenience. Expression of Tn was not confined to a single type of epithelial cancer. Staining of the non-neoplastic 'normal' cells adjacent to the tumour was not seen. However, fine supra-nuclear punctate staining was seen in some normal glandular cells (Figure 2 and Table I ), but the appearance was quite different from that seen in malignancy (Figure 3) .
The findings in lymphomas and lymphoid tissue differed from those for epithelial tumours. Staining of dendritic processes was seen in normal and reactive lymph nodes, but diffuse cell staining was seen in only 1 case and some lymphomas.
The importance of Tn with respect to tumour biology and the relationship between tumour and host remains to be determined. It is possible that expression of Tn may be an epiphenomenon of little basic importance but several observations suggest that this may not be the case. The fact that the Tn epitope is observed on carcinoma cells arising from a variety of different tissues indicates that the epitope is not tissue specific but may have a wider importance. Cells expressing Tn on their membrane show alterations in surface charge and adhesiveness (Springer et al., 1983) and such alterations could be involved in the ability of malignant cells to infiltrate and metastasize. Normal individuals can mount an immune reaction against Tn, which raises the possibility that expression of Tn may influence the interaction between tumour and host. Leukaemic cells may show expression of Tn and we have observed two patients, one with acute myeloid leukaemia in whom Tn positive cells could not be detected at initial presentation but gradually increased in number as the disease progressed until the whole leukaemic population was Tn positive at final relapse (Roxby et al., 1986) and the other with myelodysplasia in whom a clone of Tn positive cells is gradually increasing in number. These findings could be' interpreted as indicating a relationship between Tn expression and disease progression.
Irrespective of any more fundamental importance of the expression of Tn, the present results raise the possibility that it may provide a valuable diagnostic marker for carcinoma cells. Whether this type of application will be feasible is uncertain and will depend on the results of study of archival material and of material from pre-neoplastic tissues in addition to neoplastic and normal tissues. Both these applications are the subject of further investigation.
